Ardent Health Statistics
Total Valuation
Ardent Health has a market cap or net worth of $1.85 billion. The enterprise value is $3.63 billion.
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025, after market close.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ardent Health has 143.04 million shares outstanding. The number of shares has decreased by -71.90% in one year.
| Current Share Class | 143.04M |
| Shares Outstanding | 143.04M |
| Shares Change (YoY) | -71.90% |
| Shares Change (QoQ) | -0.09% |
| Owned by Insiders (%) | 1.25% |
| Owned by Institutions (%) | 19.21% |
| Float | 24.41M |
Valuation Ratios
The trailing PE ratio is 7.90 and the forward PE ratio is 6.37. Ardent Health's PEG ratio is 1.11.
| PE Ratio | 7.90 |
| Forward PE | 6.37 |
| PS Ratio | 0.29 |
| Forward PS | 0.28 |
| PB Ratio | 1.58 |
| P/TBV Ratio | 8.35 |
| P/FCF Ratio | 15.64 |
| P/OCF Ratio | 6.07 |
| PEG Ratio | 1.11 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 6.67, with an EV/FCF ratio of 30.66.
| EV / Earnings | 16.15 |
| EV / Sales | 0.60 |
| EV / EBITDA | 6.67 |
| EV / EBIT | 9.14 |
| EV / FCF | 30.66 |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 1.46.
| Current Ratio | 2.12 |
| Quick Ratio | 1.61 |
| Debt / Equity | 1.46 |
| Debt / EBITDA | 2.85 |
| Debt / FCF | 19.27 |
| Interest Coverage | 6.56 |
Financial Efficiency
Return on equity (ROE) is 23.35% and return on invested capital (ROIC) is 6.79%.
| Return on Equity (ROE) | 23.35% |
| Return on Assets (ROA) | 5.22% |
| Return on Invested Capital (ROIC) | 6.79% |
| Return on Capital Employed (ROCE) | 9.73% |
| Revenue Per Employee | $241,938 |
| Profits Per Employee | $9,023 |
| Employee Count | 24,900 |
| Asset Turnover | 1.27 |
| Inventory Turnover | 22.72 |
Taxes
In the past 12 months, Ardent Health has paid $67.87 million in taxes.
| Income Tax | 67.87M |
| Effective Tax Rate | 17.83% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 13.61 |
| 200-Day Moving Average | 15.52 |
| Relative Strength Index (RSI) | 37.21 |
| Average Volume (20 Days) | 267,792 |
Short Selling Information
The latest short interest is 1.58 million, so 1.10% of the outstanding shares have been sold short.
| Short Interest | 1.58M |
| Short Previous Month | 1.65M |
| Short % of Shares Out | 1.10% |
| Short % of Float | 6.46% |
| Short Ratio (days to cover) | 5.34 |
Income Statement
In the last 12 months, Ardent Health had revenue of $6.02 billion and earned $224.68 million in profits. Earnings per share was $1.64.
| Revenue | 6.02B |
| Gross Profit | 3.45B |
| Operating Income | 397.03M |
| Pretax Income | n/a |
| Net Income | 224.68M |
| EBITDA | 544.17M |
| EBIT | 397.03M |
| Earnings Per Share (EPS) | $1.64 |
Full Income StatementBalance Sheet
The company has $503.63 million in cash and $2.28 billion in debt, giving a net cash position of -$1.78 billion or -$12.42 per share.
| Cash & Cash Equivalents | 503.63M |
| Total Debt | 2.28B |
| Net Cash | -1.78B |
| Net Cash Per Share | -$12.42 |
| Equity (Book Value) | 1.56B |
| Book Value Per Share | 8.22 |
| Working Capital | 931.13M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $304.93 million and capital expenditures -$186.58 million, giving a free cash flow of $118.35 million.
| Operating Cash Flow | 304.93M |
| Capital Expenditures | -186.58M |
| Free Cash Flow | 118.35M |
| FCF Per Share | $0.83 |
Full Cash Flow StatementMargins
Gross margin is 57.32%, with operating and profit margins of 6.59% and 3.73%.
| Gross Margin | 57.32% |
| Operating Margin | 6.59% |
| Pretax Margin | 6.32% |
| Profit Margin | 3.73% |
| EBITDA Margin | 9.03% |
| EBIT Margin | 6.59% |
| FCF Margin | 1.96% |
Dividends & Yields
Ardent Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 71.90% |
| Shareholder Yield | 71.90% |
| Earnings Yield | 12.14% |
| FCF Yield | 6.39% |
Analyst Forecast
The average price target for Ardent Health is $20.77, which is 60.51% higher than the current price. The consensus rating is "Buy".
| Price Target | $20.77 |
| Price Target Difference | 60.51% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ardent Health has an Altman Z-Score of 2.26 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.26 |
| Piotroski F-Score | 7 |